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Background: Deletion in the chromosomal region 22q11 results from the abnormal 
development of the third and fourth pharyngeal pouches during embryonic life and 
presents an expansive phenotype with more than 180 clinical features described that 
involve every organ and system.
History and signs: A 23-year-old African woman presented for the first trimester 
echography, which revealed an isolated anechoic structure suggesting a ureteral dilata-
tion. The suspicion of a malposition of great arteries in the second trimester indicated an 
amniocentesis leading to a diagnosis of 22q11 deletion.
outcome: At 32 weeks, the patient was admitted for premature rupture of membranes 
and gave birth 2 weeks later to a male newborn who presented a respiratory distress 
syndrome and probably died secondary to a tracheal stenosis. Necropsy revealed typical 
clinical features of 22q11 deletion associated with left renal agenesis, hypospadias, and 
penile hypoplasia.
Conclusion: We report a case of 22q11 deletion syndrome with typical clinical features 
associated with urogenital manifestations suspected at the first trimester ultrasound.
Keywords: 22q11 deletion syndrome, DiGeorge syndrome, CatCH22 syndrome, urogenital manifestations, renal 
agenesis, hypospadias
INtRoDUCtIoN
A 23-year-old healthy African woman, mother of a healthy child, born by C-section for obstructed 
labor, presented at 12  weeks and 5  days’ gestation of the second spontaneous pregnancy for the 
first trimester echography. The exam revealed an anechoic structure appearing like a possible right 
ureteral dilatation (Figure 1A). Both renal arteries seemed to be present with the Doppler evaluation 
(Figure 1B). First trimester scan exam including nuchal translucency was otherwise normal and 
combined test for Down syndrome has been evaluated at 1/30,000.
At 18 weeks’ gestation, we had a strong suspicion of great arteries’ malposition because of an 
abnormal three-vessel view. Regarding this suspicion, an amniocentesis was performed and revealed 
a male fetus with 22q11 deletion. The follow-up was made in a university center, and several 
echographic exams were performed. The first one at 19 week’s gestation concluded to an anomalous 
pulmonary venous return and transposition of great vessels. The left renal agenesis was discovered 
FIGURe 1 | (a) Right ureteral dilatation. (B) Doppler renal arteries.
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at 25 weeks’ gestation, and the ultrasound at 29 weeks’ gestation 
showed a conotruncal cardiopathy with malposition of great 
arteries, interventricular communication, left renal agenesis, and 
penile hypoplasia. The transposition of great vessels described 
above was nullified.
The patient presented for premature rupture of membrane at 
32 weekends and 4 days’ gestation and delivered 2 weeks later 
a male fetus of 1578 g with the following features at necropsy: 
facial anomalies with hypotelorism, wide nasal bridge, low set 
right ear and microcephaly, and limb manifestations with post-
axial bilateral hexadactyly without bone component (Figure 2). 
About urogenital anomalies, left renal agenesis and peri-
neoscrotal hypospadias with penile hypoplasia (Figure 3) with 
descended testes were found. Concerning the cardiovascular 
FIGURe 2 | postaxial bilateral hexadactyly.
FIGURe 3 | penile hypoplasia and perineoscrotal hypospadias.
FIGURe 4 | (a) Malposition of the aortic orifice and s shape of the ascending 
aorta without transposition of great vessels. (B) Two punctate interventricular 
communications.
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and respiratory system, the exam revealed pneumothorax with 
subglottic perforation and tracheal stenosis, parathyroid aplasia, 
heart defect with “s shape” of ascending aorta without transposi-
tion (Figure 4A), and two punctate interventricular communica-
tions, one muscular and the other one, sub-arterial (Figure 4B). 
The baby probably died secondary to a tracheal stenosis, which 
limited the intubation.
BaCKGRoUND
First described in 1968, deletions in the chromosomal region 
22q11 result from an anomaly of the third and fourth pharyngeal 
pouches during embryonic life (1). Also known as DiGeorge 
syndrome, velocardiofacial syndrome, and CATCH22 acronym 
(cardiac defects, abnormal faces, thymus hypoplasia, clef palate, 
and hypocalcemia) that outlines the main clinical features (2), 
this deletion presents an expansive phenotype with more than 
180 clinical features described that involve every organ and sys-
tem (3). It occurs in 1/4000 live births and constitutes the most 
frequent interstitial chromosomal aberration (4).
Researchers are working to identify all of the genes that 
contribute to the features of 22q11.2 deletion syndrome (5). 
They have determined that the loss of a particular gene on 
chromosome 22, TBX1, is probably responsible for many of 
the syndrome’s characteristic signs (such as heart defects, a 
cleft palate, distinctive facial features, hearing loss, and low 
calcium levels). The loss of additional genes in the deleted region 
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likely contributes to the varied features of 22q11.2 deletion 
syndrome (6).
DIsCUssIoN
The original description of the syndrome was derived from a pub-
lished discussion at an immunology meeting in 1965. DiGeorge 
published a formal report 3 years later.
Since then, many terms have been proposed to describe this 
syndrome. It seems appropriate to use Takao syndrome for cases 
with a preponderant cardiac presentation in contrast to the low 
T cells and hypocalcemic presentation in infancy of DiGeorge 
syndrome and the craniofacial and palatal abnormalities typical 
of Shprintzen syndrome or velocardiofacial syndrome. In 1993, 
Wilson et al. proposed to see DiGeorge syndrome as the severe 
end of the clinical spectrum embraced by the acronym CATCH22 
syndrome (7).
The acronym CATCH22 includes the classical manifestations 
as cardiac abnormality, facial abnormality, thymus hypoplasia, 
cleft palate, and hypocalcemia due to hypoparathyroidism.
However, in our case, we would like to focus on urogenital 
manifestations, whereas several authors described features in 
every organ and system.
The etiology of renal malformations in deletion 22q11 still 
remains unclear, but it is postulated that a single-gene defect 
within the DGCR is responsible for the development of the uro-
genital tract in early embryonic development (4). Described renal 
malformations in patients with 22q11 deletion syndrome are 
absent, dysplastic or multicystic kidneys, obstructive abnormali-
ties, vesicoureteral reflux, nephron calcinosis, duplex kidney, and 
affect 10–36% of patients according to the different authors (7–9). 
Concerning genital anomalies, which are less frequent, it has been 
reported cases of absent uterus, uterine didelphys, undescended 
testes, small penis, hypospadias, and shawl scrotum (8–11).
Other possible anechoic structures (ovarian cyst, intestinal 
duplication, and mesenteric cyst) usually appear in the second 
trimester. In our case, the sonographic anomaly was not present 
at the 18-week ultrasound.
CATCH22 syndrome is usually sporadic and results from 
de novo deletion within chromosome 22 without major difference 
between parents of origin (8). However, inherited transmission 
has been reported in 6–28% of patients (12), emphasizing the 
need for studying both parents when a child is found to have 
a deletion (8), the risk of a further pregnancy with monosomy 
22q11 for these couples being obviously 50% (7).
Even the largest of the published series are still too small 
to provide reliable data for counseling (8), it seems reasonable 
to offer to patients with 22q11 deletion, prenatal detection 
by choriocentesis or amniocentesis (13). Concerning normal 
parents of offspring with a de novo deletion, the recurrence 
in subsequent pregnancies is probably low, but a germline 
mosaicism for a 22q11 deletion has not been excluded (13). 
Furthermore, cytogenetic and molecular evaluation of the fetus 
for a 22q11 deletion should be systematically offered to the 
parents when a conotruncal heart malformation is detected 
prenatally. With the advent of preimplantation diagnosis, it is 
important to know that it is now feasible to detect CATCH22 
at the blastocyst stage, making the preimplantation diagnosis 
possible.
CoNCLUDING ReMaRKs
As described earlier, kidney malformations in the 22q11 syn-
drome are not so rare. Despite this, our case is distinguished 
by the discovery of prenatal abnormalities and the presence of 
several genital defects.
Although urogenital malformations are not the main sign for 
CATCH22 syndrome, it is really important to always perform 
a good morphological exam and given their prevalence in this 
syndrome, if this latter is suspected, to study precisely urinary 
and genital tract.
Many of these abnormalities require surgical or medical 
intervention to prevent complications, such as hypertension and 
renal nephropathy (8) reason, why early diagnosis and treatment 
is recommended.
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